Skip to main content
. 2015 May 6;2015:328078. doi: 10.1155/2015/328078

Figure 1.

Figure 1

Clinical features of the 245 (62.3%) anti-dsDNA + (group 1), 52 (13.3%) anti-dsDNA ± (group 2), and 96 (24.4%) anti-dsDNA − (group 3) SLE patients. P = 0.001 group 1 versus group 2 and group 1 versus group 3; § P < 0.0001 group 3 versus group 1 and group 3 versus group 2.